Literature DB >> 7460482

Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites.

H Gault, J Kalra, M Ahmed, D Kepkay, L Longerich, J Barrowman.   

Abstract

High-performance liquid chromatography (HPLC) analysis was performed on methylene chloride extracts of urine from six subjects after administration of 3H-digoxin-12 alpha and unlabeled digoxin by nasogastric tube under four conditions: pentagastrin and control saline infusions, each in the supine and ambulatory states. There were no differences with change in position. With pentagastrin stimulation of acid secretion, there was extensive intragastric hydrolysis, mainly to digoxigenin; there was further extensive biotransformation leading to an increase in both extractable and unextractable metabolites in urine, particularly the latter. In the first 5 hr mean digoxin was only 17% and unextractable metabolites were 54% of total urine radioactivity. Extractable radioactivity was found under HPLC peaks with retention times of digoxin, digoxigenin, and its mono- and bis-digitoxosides. There were also three other peaks that were not identified; two correlated with gastric H+ activity and with the peak for digoxigenin, which is probably their precursor since similar peaks were found after ingestion of digoxigenin. The third unidentified peak eluted immediately after the digoxin, with which it correlated; it may have a close structural relationship to digoxin. Gastric acid stimulation induced a major increase in the production of urinary metabolites and may prove a useful model for the study of digoxin biotransformation, which is not yet well defined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460482     DOI: 10.1038/clpt.1981.29

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.

Authors:  B Oosterhuis; J H Jonkman; T Andersson; P B Zuiderwijk; J N Jedema
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

2.  The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.

Authors:  A F Cohen; R Kroon; H C Schoemaker; D D Breimer; A Van Vliet-Verbeek; H C Brandenburg
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

3.  Effect of quinidine on digoxin bioavailability.

Authors:  K E Pedersen; B D Christiansen; N A Klitgaard; F Nielsen-Kudsk
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.

Authors:  L W Robertson; A Chandrasekaran; R H Reuning; J Hui; B D Rawal
Journal:  Appl Environ Microbiol       Date:  1986-06       Impact factor: 4.792

Review 5.  Oleandrin: A Systematic Review of its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology.

Authors:  Jinxiao Zhai; Xiaoru Dong; Fenglian Yan; Hongsong Guo; Jinling Yang
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.